期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 165, 期 8, 页码 2692-2706出版社
WILEY
DOI: 10.1111/j.1476-5381.2011.01727.x
关键词
insulin resistance; PPARa; PKA; phosphorylation; lipid metabolism
BACKGROUND AND PURPOSE The amelioration of insulin resistance by bilobetin is closely related to its hypolipidaemic effect. The aim of the present study was to determine the insulin-sensitizing mechanism of bilobetin by elucidating its effect on lipid metabolism. EXPERIMENTAL APPROACH Rats fed a high-fat diet were treated with bilobetin for either 4 or 14 days before applying a hyperinsulinaemic-euglycaemic clamp. Triglyceride and fatty acids labelled with radioactive isotopes were used to track the transportation and the fate of lipids in tissues. The activity of lipid metabolism-related enzymes and b-oxidation rate were measured. Western blot was used to investigate the phosphorylation, translocation and expression of PPARa in several tissues and cultured cells. The location of amino acid residues subjected to phosphorylation in PPARa was also studied. KEY RESULTS Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in b-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARa accompanied by elevated cAMP level and PKA activity. Threonine-129-alanine and/or serine-163-alanine mutations on the PPARa genes and PKA inhibitors prevented the effects of bilobetin on PPARa. However, cells overexpressing PKA appeared to stimulate the phosphorylation, nuclear translocation and activity of PPARa. CONCLUSIONS AND IMPLICATIONS Bilobetin treatment ameliorates hyperlipidaemia, lipotoxicity and insulin resistance in rats by stimulating PPARa-mediated lipid catabolism. PKA activation is crucial for this process.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据